The U.S. healthcare system is currently in the midst of seismic change, largely characterized by the shift from volume to value-based medicine.  Driven by this shift, population health management has gained considerable traction in recent years, with significant implications for pharma.  In her latest column for eyeforpharma, Preparing for Population Health Management, President Rita Numerof discusses this important trend, including what’s driving the transition to value as well as key considerations for pharmaceutical companies preparing for this new environment.